Vicriviroc

CAS No.

306296-47-9

MDL No.

N/A

C₂₈H₃₈F₃N₅O₂

533.60

InChI Key

CNPVJJQCETWNEU-CYFREDJKSA-N

Pack Size	Purity	Price	Availability	Action
-	-	On Request	On Request
Custom synthesis and bulk supply options are available upon request.

Pack Size

Purity

Price

Availability

Action

On Request

Custom synthesis and bulk supply options are available upon request.

Product Information

(4,6-Dimethyl-5-pyrimidinyl)-[4-[(3S)-4-[(1R)-2-methoxy-1-[4-(trifluoromethyl)phenyl]ethyl]-3-methyl-1-piperazinyl]-4-methyl-1-piperidinyl]methanone is a member of (trifluoromethyl)benzenes.

CAS No.	306296-47-9
Product Name	Vicriviroc

Biological Targets

CCR5

Associated Conditions

colorectal neoplasm·HIV infection·AIDS

* The information provided here is compiled from public sources and is for reference only.

Pricing & Availability

Product Information

Biological Profile

Properties

Biological Targets

Associated Conditions

Documentation

Vicriviroc

Pricing & Availability

Product Information

Biological Profile

Properties

Biological Targets

Associated Conditions

Related Articles

HIV type 1 chemokine coreceptor use among antiretroviral-experienced patients screened for a clinical trial of a CCR5 inhibitor: AIDS Clinical Trial Group A5211.

Access denied? The status of co-receptor inhibition to counter HIV entry.

Report from the 13th retrovirus conference. Vicriviroc less effective than efavirenz in treatment-naive patients.

Potent antiviral synergy between monoclonal antibody and small-molecule CCR5 inhibitors of human immunodeficiency virus type 1.

Documentation

Similar Products

Vicriviroc Maleate